StonvexLoading…
StonvexStonvexStonvexCore line items from CRUS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-12-27 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 | Annual 2025 2025-03-29 |
|---|---|---|---|---|
Revenue | $1.55B | $968.23M | $407.27M | $1.90B |
Operating Income | $370.08M | $217.16M | $72.39M | $410.36M |
Net Income | $332.60M | $192.29M | $60.70M | $331.51M |
EPS (Diluted) | $6.27 | $3.61 | $1.14 | $6.00 |
Total Assets | $2.46B | $2.43B | $2.29B | $2.33B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $778.08M | $593.48M | $548.87M | $539.62M |
Free Cash Flow OCF − CapEx | $487.59M | $201.84M | $113.49M | $421.59M |
Shares Outstanding | 53.04M | 53.20M | 53.32M | 52.29M |